Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Deal Details

C/PIndustryStatusTicker(s)Issuer(s)Size(m)TranchesRegionDate
HYC
CONS
PRCD
ONTEX
Ontex Group NV€580
1EMEA
Jun 29, 2021
currency
EUR
size (m)
580.000
maturity
Jul 15, 2026
type
Fixed
tenor
5.000
call
2
registration
Reg S Only
benchmark
-
ranking
Sr. Unsecured
moody's
B1
s&p
BB-
fitch
-
size description
-
re-open/tap
No
ipt
high 3s
ipt-pxd
-
guidance
3.50-3.75%
spread
407
coupon
3.500%
spread set
-
price
100.00000
yield
3.500%
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
joint leads
passive leads
co-managers
-
coordinating managers
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
-
left lead
active leads
joint leads
passive leads
co-managers
-
coordinating managers
Tranche Comments
Redemption: 2023-07-15; Registration: Reg S Only;
Deal Comments
06/29/2021 Ontex Group NV (ONTEX) EUR580m Reg S sr notes due 07/15/26 (5y). NC2 (MWC B+50bp), then at 101.750 100.875, 100. Equity claw: 2y 40% at 103.50. B1/BB- (stable/negative)). Via BNP/BoA/GS (B&D) jt glocos and physical books/CA/HSBC/ING jt books, KBC, SocGen passive books. List Lux. NY law. Settles 07/07. ISIN: BE6329443962. IPT: high 3s. Px talk: 3.50%-3.75%. Priced: 3.50% at 100. +407bp vs OBL 0% 04/10/26. Did investor call at 10:30am UKT 06/28. Also did roadshow 06/22-24. Books closed at 11am UKT 06/29. UOP: along with a new EUR220m term loan to repay in full its existing EUR150m Bilateral facility, EUR30m revolver and EUR600m term loan. Biz: a leading provider of personal hygiene products worldwide. HQ: Aalst-Erembodegem, Belgium.

Commentary

Explore all other Commentary & Deal Flow

Deal Flow

Explore all other Commentary & Deal Flow
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.